AION-301 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-01 (month) in 3mo
ESTIMATED |
READOUT
A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With A
Phase 1/2 · Chronic Kidney Disease Stage 3 |
AION Healthspan, Inc. | AION-301 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|